Status:
COMPLETED
Acupuncture for Low-Dose Opioid for TKA Replacement
Lead Sponsor:
Hospital for Special Surgery, New York
Conditions:
Knee Osteoarthritis
Pain, Postoperative
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The majority of patients undergoing total knee replacement(TKR) rely on opioids for postoperative analgesia. These medications have undesirable side effects and potential for abuse and addiction. The ...
Detailed Description
This is a prospective cohort study to assess the feasibility of patients to undergo TKR while adhering to a low-dose opioid regimen by using a multimodal analgesic approach that includes intraoperativ...
Eligibility Criteria
Inclusion
- ASA of 1 or 2
- Age 18-70
- Undergoing primary total knee replacement
- Desire to attempt a low opioid or opioid free pathway
Exclusion
- NonEnglish speaking
- Patients with the inability to understand or follow study protocol
- Opioid use in the last 6 weeks or chronic pain patient
- Cannot receive neuraxial anesthesia and/or peripheral nerve block
- Patients with contraindications to intraop protocol (e.g., patient cannot take acetaminophen or ketorolac due to liver or kidney disease)
- Patients with implanted cardiac device such as a pacemaker or AICD
- Active ear infection
- Nonnative ear, previous scarring or surgical manipulation of ear
- Patients with gauges or other deforming ear piercing (small nondeforming ear piercings are ok) present in ears
- Allergy to nickel
Key Trial Info
Start Date :
August 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 2 2020
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04084288
Start Date
August 21 2019
End Date
October 2 2020
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021